ASTRAZENECA DL-,25 SP.ADR/ US0463531089 /
17/06/2024 8:13:51 | Diferencia 0.000 | Volumen | Bid10:56:21 | Ask10:56:21 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
74.000EUR | 0.00% | - Volumen de negocios: - |
73.500Volumen de oferta: 1,000 | 74.000Tamaño/ Volumen/ Formato de Ask: 250 | 227.83 mil millonesEUR | - | - |
GlobeNewswire
11:39
Correction: Amarna Therapeutics announces formation of Scientific Advisory Board to support advancem...
GlobeNewswire
11:23
Amarna Therapeutics announces formation of Scientific Advisory Board to support advancement of groun...
GlobeNewswire
10:20
Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immu...
Newsfile Corp
10:19
Shelf Gains Adaptation Among SMBs and Enterprises, Grows Double Digits in US and Canadian Market
GlobeNewswire
10:00
Castle Ridge announces launch of Multi-Strategy powered by WALLACE AI supercomputer
GlobeNewswire
10:00
Cognitiv Partners With Adform to Offer ContextGPT™ to European Advertisers for the First Time
GlobeNewswire
10:00
GDRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investor...
GlobeNewswire
10:00
SHCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sharecare Inc. Investors with ...
GlobeNewswire
10:00
INTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intel Corporation Investors wi...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página